Edition:
India

Corvus Pharmaceuticals Inc (CRVS.OQ)

CRVS.OQ on NASDAQ Stock Exchange Global Market

3.51USD
1:30am IST
Change (% chg)

$-0.16 (-4.36%)
Prev Close
$3.67
Open
$3.64
Day's High
$3.80
Day's Low
$3.46
Volume
50,764
Avg. Vol
56,625
52-wk High
$11.15
52-wk Low
$3.22

About

Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology therapies. The Company is developing drugs and antibodies that block crucial immune checkpoints and reprogram immune T-cells. The Company has a pipeline of four immuno-onc... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $115.55
Shares Outstanding(Mil.): 29.33
Dividend: --
Yield (%): --

Financials

Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates